Citation: Lu Wenyu, Yu Wenjing, Sun Dequn. Advances in Application of Marine Bioactive Peptides in Drug Development[J]. Chinese Journal of Organic Chemistry, ;2017, 37(7): 1681-1700. doi: 10.6023/cjoc201612062 shu

Advances in Application of Marine Bioactive Peptides in Drug Development

Marine College, Shandong University at Weihai, Weihai 264209

Corresponding author: Sun Dequn, dequn.sun@sdu.edu.cn
Received Date: 26 December 2016
Revised Date: 14 February 2017
Available Online: 31 July 2017

Figures(23)

The ocean is the most resource-rich area on earth. The living environment of marine life is complicated, so that they form a special structure of the active substances. Coupled with the progress of science and technology, people are increasingly concerned about how to find new active substances from marine life, which makes the marine bioactive peptide is widely concerned. Bioactive peptides have a variety of activities, the study shows that these substances have antioxidant, antihypertensive, anti-virus and anti-tumor activity. It has the advantages of low toxicity, high targeting specificity and strong biological activity. At present, some of bioactive peptides extracted from sea cucumbers, conus, ascidians, sponges, marine fungi, molluscs, or analogues derived from these compounds have entered the market or clinical stage. The current research status of marine bioactive peptides is reviewed including their source, synthetic method, chemical structure, activity, mechanism, clinical efficacy and safety. Research prospects in this field are discussed.
- marine peptide,
- bioactivity,
- pharmaceutical,
- clinical trial
1. [1]
  Cheung, R. C.; Ng, T. B.; Wong, J. H. Mar. Drugs 2015, 13, 4006. doi: 10.3390/md13074006
2. [2]
  Jin, L.; Quan, C.; Hou, X.; Fan, S. Mar. Drugs 2016, 14, 76. doi: 10.3390/md14040076
3. [3]
  (a) Suarez-Jimenez, G. M.; Burgos-Hernandez, A.; Ezquerra-Brauer, J. M. Mar. Drugs 2012, 10, 963.
  (b) Ponnappan, N.; Budagavi, D. P.; Yadav, B. K.; Chugh, A. Probiotics Antimicro. Proteins 2015, 7, 75.
4. [4]
  (a) Lordan, S.; Ross, R. P.; Stanton, C. Mar. Drugs 2011, 9, 1056.
  (b) Kim, S. K.; Wijesekara, I. J. Funct. Foods 2010, 2, 1.
5. [5]
  Romano, G.; Costantini, M.; Sansone, C.; Lauritano, C.; Ruocco, N.; Ianora, A. Mar. Environ. Res. 2017, 128, 58. doi: 10.1016/j.marenvres.2016.05.002
6. [6]
  Aneiros, A.; Garateix, A. J. Chromatogr. B:Anal. Technol. Biomed. Life Sci. 2004, 803, 41. doi: 10.1016/j.jchromb.2003.11.005
7. [7]
  Pan, X.; Zhao, Y. Q.; Hu, F. Y.; Wang, B. J. Funct. Foods 2016, 25, 220. doi: 10.1016/j.jff.2016.06.008
8. [8]
  Ngo, D. H.; Vo, T. S.; Ngo, D. N.; Wijesekara, I.; Kim, S. K. Int. J. Biol. Macromol. 2012, 51, 378. doi: 10.1016/j.ijbiomac.2012.06.001
9. [9]
  Castro, R. J. S. D.; Sato, H. H. Food Res. Int. 2015, 74, 185. doi: 10.1016/j.foodres.2015.05.013
10. [10]
  Kang, H. K.; Seo, C. H.; Park, Y. Mar. Drugs 2015, 13, 618. doi: 10.3390/md13010618
11. [11]
  Lee, J. K.; Jeon, J. K.; Byun, H. G. J. Funct. Foods 2014, 7, 381. doi: 10.1016/j.jff.2014.01.021
12. [12]
  Zhan, K. X.; Jiao, W. H.; Yang, F.; Li, J.; Wang, S. P.; Li, Y. S.; Han, B. N.; Lin, H. W. J. Nat. Prod. 2014, 77, 2678. doi: 10.1021/np5006778
13. [13]
  Liu, C.-C.; Xu, X.-L.; Kong, Y.-L.; Zhang, X.-L.; Wang, C.; Zhuang, B.; Fan, Y.-F.; Zhang, G.-T.; Wang, C. Chin. J. Mar. Drugs 2015, 34, 73.
14. [14]
  (a) Pettit, G. R.; Kamano, Y.; Herald, C. L.; Tuinman, A. A.; Boettner, F. E.; Kizu, H.; Schmidt, J. M.; Baczynskyj, L.; Tomer, K. B.; Bontems, R. J. J. Am. Chem. Soc. 1987, 109, 6883.
  (b) Pettit, G. R. Fortschritte der Chemie Organischer Naturstoffe: Progress in the Chemistry of Organic Natural Products, Vol. 70, Springer-Verlag, Wien, 1997, pp. 1~99.
  (c) Pettit, G. R.; Kamano, Y.; Herald, C. L.; Fujii, Y.; Kizu, H.; Boyd, M. R.; Boettner, F. E.; Doubek, D. L.; Schmidt, J. M.; Chapuis, J. C. Tetrahedron 1993, 49, 9151.
15. [15]
  Miyazaki, K.; Kobayashi, M.; Natsume, T.; Gondo, M.; Mikami, T.; Sakakibara, K.; Tsukagoshi, S. Chem. Pharm. Bull. 1995, 43, 1706. doi: 10.1248/cpb.43.1706
16. [16]
  Mordant, C.; Reymond, S.; Tone, H.; Lavergne, D.; Touati, R.; Hassine, B. B.; Ratovelomanana-Vidal, V.; Genet, J. P. Tetrahedron 2007, 63, 6115. doi: 10.1016/j.tet.2007.03.036
17. [17]
  (a) Kalemkerian, G. P.; Ou, X.; Adil, M. R.; Rosati, R.; Khoulani, M. M.; Madan, S. K.; Pettit, G. R. Cancer Chemother. Pharmacol. 1999, 43, 507.
  (b) Pettit, R. K.; Pettit, G. R.; Hazen, K. C. Antimicrob. Agents Chemother. 1998, 42, 2961.
  (c) Poncet, J.; Busquet, M.; Roux, F.; Pierr, A., Atassi, G.; Jouin, P. J. Med. Chem. 1998, 41, 1524.
18. [18]
  Perez, E. A.; Hillman, D. W.; Fishkin, P. A.; Krook, J. E.; Tan, W. W.; Kuriakose, P. A.; Alberts, S. R.; Dakhil, S. R. Invest. New Drugs 2005, 23, 257. doi: 10.1007/s10637-005-6735-y
19. [19]
  Kindler, H. L.; Tothy, P. K.; Wolff, R.; Mccormack, R. A.; Abbruzzese, J. L.; Mani, S.; Wade-Oliver, K. T.; Vokes, E. E. Invest. New Drugs 2005, 23, 489. doi: 10.1007/s10637-005-2909-x
20. [20]
  Maderna, A.; Doroski, M.; Subramanyam, C.; Porte, A.; Leverett, C. A.; Vetelino, B. C.; Chen, Z.; Risley, H.; Parris, K.; Pandit, J. J. Med. Chem. 2014, 57, 10527. doi: 10.1021/jm501649k
21. [21]
  (a) Diamantis, N.; Banerji, U. Br. J. Cancer 2016, 114, 362.
  (b) Bakhtiar, R. Biotechnol. Lett. 2016, 38, 1.
  (c) Gébleux, R.; Casi, G. Pharmacol. Ther. 2016, 167, 48
22. [22]
  Thomas, A.; Teicher, B. A.; Hassan, R. Lancet Oncol. 2016, 17, e254. doi: 10.1016/S1470-2045(16)30030-4
23. [23]
  Wang, Y.-M.; Hao, B.-J.; Zhong, W.; Li, S. J. Int. Pharm. Res. 2015, 42, 427.
24. [24]
  Newman, D. J.; Cragg, G. M. Mar. Drugs 2014, 12, 255. doi: 10.3390/md12010255
25. [25]
  Senter, P. D.; Sievers, E. L. Nat. Biotechnol. 2012, 30, 631. doi: 10.1038/nbt.2289
26. [26]
  (a) Ansell, S. M. Blood 2014, 124, 3197.
  (b) Deng, C.; Pan, B.; O'Connor, O. A. Clin. Cancer Res. 2013, 19, 22.
  (c) Okeley, N. M.; Miyamoto, J. B.; Zhang, X.; Sanderson, R. J.; Benjamin, D. R.; Sievers, E. L.; Senter, P. D.; Alley, S. C. Clin. Cancer Res. 2010, 16, 888.
27. [27]
  (a) Francisco, J. A.; Cerveny, C. G.; Meyer, D. L.; Mixan, B. J.; Klussman, K.; Chace, D. F.; Rejniak, S. X.; Gordon, K. A.; Deblanc, R.; Toki, B. E.; Law, C. L. Blood 2003, 102, 1458.
  (b) Pettit, G. R.; Barkoczy, J. US 5635483, 1997 [Chem. Abstr. 1997, 122, 133848].
28. [28]
  Moskowitz, C. H.; Nademanee, A.; Masszi, T.; Agura, E.; Holowiecki, J.; Abidi, M. H.; Chen, A. I.; Stiff, P.; Gianni, A. M.; Carella, A. Lancet 2015, 385, 1853. doi: 10.1016/S0140-6736(15)60165-9
29. [29]
  Reilly, E. B.; Phillips, A. C.; Boghaert, E. R.; Vaidya, K. S.; Mitten, M. J.; Norvell, S.; Falls, H. D.; Devries, P. J.; Cheng, D.; Meulbroek, J. A. Mol. Cancer Ther. 2016, 15, 661. doi: 10.1158/1535-7163.MCT-15-0901
30. [30]
  https://www.fda.gov/
31. [31]
  Reilly, E. B.; Phillips, A. C.; Buchanan, F. G.; Kingsbury, G.; Zhang, Y.; Meulbroek, J. A.; Cole, T. B.; Devries, P. J.; Falls, H. D.; Beam, C. Mol. Cancer Ther. 2015, 14, 1141. doi: 10.1158/1535-7163.MCT-14-0820
32. [32]
  Doronina, S. O.; Mendelsohn, B. A.; Bovee, T. D.; Cerveny, C. G.; Alley, S. C.; Meyer, D. L.; Oflazoglu, E.; Toki, B. E.; Sanderson, R. J.; Zabinski, R. F. Bioconjugate Chem. 2006, 17, 114. doi: 10.1021/bc0502917
33. [33]
  Gan, H. K.; Fichtel, L.; Lassman, A. B.; Merrell, R.; Van, D. B., Martin J.; Kumthekar, P.; Scott, A. M.; Pedersen, M.; Gomez, E.; Fischer, J. D. J. Clinical Oncol. 2014, 32, 2021
34. [34]
  (a) Vaklavas, C.; Forero, A. BioDrugs 2014, 28, 253.
  (b) Roth, M.; Barris, D. M.; Piperdi, S.; Kuo, V.; Everts, S.; Geller, D.; Houghton, P.; Kolb, E. A.; Hawthorne, T.; Gill, J. Pediatr. Blood Cancer 2016, 63, 32.
  (c) Keir, C. H.; Vahdat, L. T. Expert Opin. Biol. Ther. 2012, 12, 259.
35. [35]
  Yardley, D. A.; Weaver, R.; Melisko, M. E.; Saleh, M. N.; Arena, F. P.; Forero, A.; Cigler, T.; Stopeck, A.; Citrin, D.; Oliff, I. J. Clin. Oncol. 2015, 33, 1609. doi: 10.1200/JCO.2014.56.2959
36. [36]
  Mehta, A.; Forero-Torres, A. Curr. Oncol. Rep. 2015, 17, 1. doi: 10.1007/s11912-014-0425-x
37. [37]
  Palanca-Wessels, M. C. A.; Czuczman, M.; Salles, G.; Assouline, S.; Sehn, L. H.; Flinn, I.; Patel, M. R.; Sangha, R.; Hagenbeek, A.; Advani, R. Lancet Oncol. 2015, 16, 704. doi: 10.1016/S1470-2045(15)70128-2
38. [38]
  (a) Pereira, D. S.; Guevara, C. I.; Jin, L.; Mbong, N.; Verlinsky, A.; Hsu, S. J.; Aviña, H.; Karki, S.; Abad, J. D.; Yang, P. Mol. Cancer Ther. 2015, 14, 1650.
  (b) Lapalombella, R.; Yeh, Y. Y.; Wang, L.; Ramanunni, A.; Rafiq, S.; Jha, S.; Staubli, J.; Lucas, D. M.; Mani, R.; Herman, S. E. M. Cancer Cell 2012, 21, 694.
39. [39]
  Sawas, A.; Savage, K. J.; Perez, R.; Advani, R. H.; Butturini, A.; Lackey, J.; Trave, F.; Anand, B.; Huang, Y.; Reyno, L. Nature 2015, 128, 413.
40. [40]
  Akashi, Y.; Okamoto, I.; Suzuki, M.; Tamura, K.; Iwasa, T.; Hisada, S.; Satoh, T.; Nakagawa, K.; Ono, K.; Fukuoka, M. Br. J. Cancer 2007, 96, 1532. doi: 10.1038/sj.bjc.6603769
41. [41]
  Otani, M.; Natsume, T.; Watanabe, J. I.; Kobayashi, M.; Murakoshi, M.; Mikami, T.; Nakayama, T. Cancer Sci. 2000, 91, 837.
42. [42]
  Watanabe, J.; Natsume, T.; Fujio, N.; Miyasaka, K.; Kobayashi, M. Apoptosis 2000, 5, 345. doi: 10.1023/A:1009687609330
43. [43]
  Patel, S.; Keohan, M. L.; Saif, M. W.; Rushing, D.; Baez, L.; Feit, K.; Dejager, R.; Anderson, S. Cancer 2006, 107, 2881. doi: 10.1002/(ISSN)1097-0142
44. [44]
  Riely, G. J.; Gadgeel, S.; Rothman, I.; Saidman, B.; Sabbath, K.; Feit, K.; Kris, M. G.; Rizvi, N. A. Lung Cancer 2007, 55, 181. doi: 10.1016/j.lungcan.2006.10.002
45. [45]
  Jordan, M. A.; Walker, D.; Arruda, M. D.; Barlozzari, T.; Panda, D. Biochemistry 1999, 37, 17571.
46. [46]
  (a) Ray, A.; Okouneva, T.; Manna, T.; Miller, H. P.; Schmid, S.; Arthaud, L.; Luduena, R.; Jordan, M. A.; Wilson, L. Cancer Res. 2007, 67, 3767.
  (b) Bai, R.; Edler, M. C.; Bonate, P. L.; Copeland, T. D.; Pettit, G. R.; Ludueña, R. F.; Hamel, E. Mol. Pharmacol. 2009, 75, 218.
47. [47]
  Mita, A. C.; Hammond, L. A.; Bonate, P. L.; Weiss, G.; Mccreery, H.; Syed, S.; Garrison, M.; Chu, Q. S.; Debono, J. S.; Jones, C. B. Clin. Cancer Res. 2006, 12, 5207. doi: 10.1158/1078-0432.CCR-06-0179
48. [48]
  De, A. M.; Cocchiaro, C. A.; Nelson, C. M.; Grinnell, C. M.; Janssen, B.; Haupt, A.; Barlozzari, T. Cancer Res. 1995, 55, 3085.
49. [49]
  Kerbrat, P.; Dieras, V.; Pavlidis, N.; Ravaud, A.; Wanders, J.; Fumoleau, P. Eur. J. Cancer 2003, 39, 317. doi: 10.1016/S0959-8049(02)00531-2
50. [50]
  (a) Schroeder, C. I.; Craik, D. J. Future Med. Chem. 2012, 4, 1243.
  (b) Vetter, I.; Lewis, R. J. Curr. Top. Med. Chem. 2012, 12, 1546.
51. [51]
  (a) Durek, T.; Craik, D. J. Expert Opin. Ther. Pat. 2015, 25, 1.
  (b) Livett, B. G.; Gayler, K. R.; Khalil, Z. Curr. Med. Chem. 2004, 11, 1715.
52. [52]
  Schmidtko, A.; Lajevardi, J.; Freynhagen, R.; Geisslinger, G. Lancet 2010, 375, 1569. doi: 10.1016/S0140-6736(10)60354-6
53. [53]
  Dong, S.-L.; Cao, S.; Chen, Q.; Chang, M.; Peng, Y.-L. CN 103242441, 2013[Chem. Abstr. 2013, 159, 371454].
54. [54]
  Miljanich, G. P. Curr. Med. Chem. 2004, 11, 3029. doi: 10.2174/0929867043363884
55. [55]
  Williams, J. A.; Day, M.; Heavner, J. E. Expert Opin. Pharmacother. 2008, 9, 1575. doi: 10.1517/14656566.9.9.1575
56. [56]
  Staats, P. S.; Yearwood, T.; Charapata, S. G.; Presley, R. W.; Wallace, M. S.; Byas-Smith, M.; Fisher, R.; Bryce, D. A.; Mangieri, E. A.; Luther, R. R. J. Am. Med. Assoc. 2004, 291, 63. doi: 10.1001/jama.291.1.63
57. [57]
  Vera, M. D.; Joullié, M. M. Med. Res. Rev. 2002, 22, 102. doi: 10.1002/med.v22:2
58. [58]
  Geldof, A. A.; Mastbergen, S. C.; Henrar, R. E.; Faircloth, G. T. Cancer Chemother. Pharmacol. 1999, 44, 312. doi: 10.1007/s002800050983
59. [59]
  Stewart, J. A.; Low, J. B.; Roberts, J. D.; Blow, A. Cancer 1991, 68, 2550. doi: 10.1002/(ISSN)1097-0142
60. [60]
  Hamada, Y.; Kondo, Y.; Shibata, M.; Shioiri, T. J. Am. Chem. Soc. 1989, 111, 669. doi: 10.1021/ja00184a041
61. [61]
  Kucuk, O.; Young, M. L.; Habermann, T. M.; Wolf, B. C.; Jimeno, J.; Cassileth, P. A. Am. J. Clin. Oncol. 2000, 23, 273. doi: 10.1097/00000421-200006000-00013
62. [62]
  Danu, A.; Willekens, C.; Ribrag, V. Expert Opin. Orphan Drugs 2013, 1, 569. doi: 10.1517/21678707.2013.808995
63. [63]
  (a) Galmarini, C. M.; D'Incalci, M.; Allavena, P. Mar. Drugs 2014, 12, 719.
  (b) Mitsiades, C. S.; Ocio, E. M.; Pandiella, A.; Maiso, P.; Gajate, C.; Garayoa, M.; Vilanova, D.; Montero, J. C.; Mitsiades, N.; Mcmullan, C. J. Cancer Res. 2008, 68, 5216.
64. [64]
  Jou, G.; Gonzalez, I.; Albericio, F.; Lloyd-Williams, P.; Giralt, E. J. Org. Chem. 1997, 62, 354. doi: 10.1021/jo961932h
65. [65]
  Mateos, M. V.; Cibeira, M. T.; Richardson, P. G.; Prosper, F.; Oriol, A.; De, l. R. J.; Lahuerta, J. J.; García-Sanz, R.; Extremera, S.; Szyldergemajn, S. Clin. Cancer Res. 2010, 16, 3260. doi: 10.1158/1078-0432.CCR-10-0469
66. [66]
  Rawat, D. S.; Joshi, M. C.; Joshi, P.; Atheaya, H. Anti-Cancer Agents Med. Chem. 2006, 6, 33. doi: 10.2174/187152006774755519
67. [67]
  (a) Anderson, H. J.; Coleman, J. E.; Andersen, R. J.; Roberge, M. Cancer Chemother. Pharmacol. 1996, 39, 223.
  (b) Coleman, J. E.; Silva, E. D. D.; Kong, F.; Andersen, R. J.; Allen, T. M. J. Nat. Prod. 1996, 27, 10653.
68. [68]
  Nieman, J. A.; Coleman, J. E.; Wallace, D. J.; Piers, E.; Lim, L. Y.; Roberge, M.; Andersen, R. J. J. Nat. Prod. 2003, 66, 183. doi: 10.1021/np020375t
69. [69]
  Niu, C.; Ho, D. M.; Williamson, R. T.; Zask, A.; Ayral-Kaloustian, S. Bioorg. Med. Chem. Lett. 2010, 20, 1535. doi: 10.1016/j.bmcl.2010.01.047
70. [70]
  Zask, A.; Birnberg, G.; Cheung, K.; Kaplan, J.; Niu, C.; Norton, E.; Suayan, R.; Yamashita, A.; Cole, D.; Tang, Z.; Krishnamurthy, G.; Williamson, R.; Khafizova, G.; Musto, S.; Hernandez, R.; Annable, T.; Yang, X.; Discafani, C.; Beyer, C.; Greenberger, L. M.; Loganzo, F.; Ayral-Kaloustian, S. J. Med. Chem. 2004, 47, 4774. doi: 10.1021/jm040056u
71. [71]
  Loganzo, F.; Discafani, C. M.; Annable, T.; Beyer, C.; Musto, S.; Hari, M.; Tan, X.; Hardy, C.; Hernandez, R.; Baxter, M. Cancer Res. 2003, 63, 1838.
72. [72]
  (a) Vashist, Y. K.; Tiffon, C.; Stoupis, C.; Redaelli, C. A. World J. Gastroenterol. 2006, 12, 6771.
  (b) Hadaschik, B. A.; Ettinger, S.; Sowery, R. D.; Zoubeidi, A.; Andersen, R. J.; Roberge, M.; Gleave, M. E. Int. J. Cancer 2008, 122, 2368.
  (c) Hadaschik, B. A.; Adomat, H.; Fazli, L.; Fradet, Y.; Andersen, R. J.; Gleave, M. E.; So, A. I. Clin. Cancer Res. 2008, 14, 1510.
73. [73]
  Kuznetsov, G.; Tendyke, K.; Towle, M. J.; Cheng, H.; Liu, J.; Marsh, J. P.; Schiller, S. E.; Spyvee, M. R.; Yang, H.; Seletsky, B. M. Mol. Cancer Ther. 2009, 8, 2852. doi: 10.1158/1535-7163.MCT-09-0301
74. [74]
  Kowalczyk, J. J.; Kuznetsov, G.; Schiller, S.; Seletsky, B. M.; Spyvee, M.; Yang, H. WO 2003082268, 2003[Chem. Abstr. 2003, 139, 308008].
75. [75]
  Rochalima, C. M.; Bayraktar, S.; Macintyre, J.; Raez, L.; Flores, A. M.; Ferrell, A.; Rubin, E. H.; Poplin, E. A.; Tan, A. R.; Lucarelli, A. Cancer 2012, 118, 4262. doi: 10.1002/cncr.27428
76. [76]
  (a) Yamazaki, Y.; Tanaka, K.; Nicholson, B.; Deyanatyazdi, G.; Potts, B.; Yoshida, T.; Oda, A.; Kitagawa, T.; Orikasa, S.; Kiso, Y. J. Med. Chem. 2012, 55, 1056.
  (b) Hayashi, Y.; Orikasa, S.; Tanaka, K.; Kanoh, K.; Kiso, Y. J. Org. Chem. 2000, 65, 8402.
77. [77]
  Kingston, D. G. I. J. Nat. Prod. 2009, 72, 507. doi: 10.1021/np800568j
78. [78]
  Yamazaki, Y.; Sumikura, M.; Hidaka, K.; Yasui, H.; Kiso, Y.; Yakushiji, F.; Hayashi, Y. Bioorg. Med. Chem. 2010, 18, 3169. doi: 10.1016/j.bmc.2010.03.037
79. [79]
  Nicholson, B.; Lloyd, G. K.; Miller, B. R.; Palladino, M. A.; Kiso, Y.; Hayashi, Y.; Neuteboom, S. T. Anti-Cancer Drugs 2006, 17, 25. doi: 10.1097/01.cad.0000182745.01612.8a
80. [80]
  Ferrer, E.; Bolos, J.; Castañer, R. Drugs Future 2010, 35, 11. doi: 10.1358/dof.2010.035.01.1439262
81. [81]
  Heist, R. S.; Aren, O. R.; Mita, A. C.; Polikoff, J.; Bazhenova, L.; Lloyd, G. K.; Mikrut, W.; Reich, S. D.; Spear, M. A.; Huang, L. J. Clin. Oncol. 2014, 8054.
82. [82]
  (a) Stokvis, E.; Rosing, H.; López-Lázaro, L.; Rodriguez, I.; Jimeno, J. M.; Supko, J. G.; Schellens, J. H.; Beijnen, J. H. J. Mass Spectrom. 2002, 37, 992.
  (b) Lopezmacia, A.; Jimenez, J. C.; Royo, M.; Giralt, E.; Albericio, F. J. Am. Chem. Soc. 2001, 123, 11398.
83. [83]
  Janmaat, M. L.; Rodriguez, J. A.; Jimeno, J.; Kruyt, F. A.; Giaccone, G. Mol. Pharmacol. 2005, 68, 502.
84. [84]
  Suarez, Y.; Gonzalez, L.; Cuadrado, A.; Berciano, M.; Lafarga, M.; Munoz, A. Mol. Cancer Ther. 2003, 2, 863.
85. [85]
  Martin-Algarra, S.; Espinosa, E.; Rubio, J.; Lopez Lopez, J. J.; Manzano, J. L.; Carrion, L. A.; Plazaola, A.; Tanovic, A.; Pazares, L. Eur. J. Cancer 2009, 45, 732. doi: 10.1016/j.ejca.2008.12.005
86. [86]
  Coronado, C.; Galmarini, C. M.; Alfaro, V.; Yovine, A. Drugs Future 2010, 35, 287. doi: 10.1358/dof.2010.035.04.1497635
87. [87]
  (a) Teixido, C.; Mares, R.; Aracil, M.; Ramon, Y. C. S.; Hernandezlosa, J. PloS One 2013, 8, e53645.
  (b) Serova, M.; Gramont, A. D.; Bieche, I.; Riveiro, M. E.; Galmarini, C. M.; Aracil, M.; Jimeno, J.; Faivre, S.; Raymond, E. Mar. Drugs 2013, 11, 944.
  (c) Molinaguijarro, J. M.; Garcia, C.; Macias, A.; Moreno, C.; Reyes, F.; Martínezleal, J. F.; Fernandez, R.; Martinez, V.; Valenzuela, C.; Lillo, M. P. PloS One 2015, 10, e0140782.
  (d) Hajdu, T. Ageing Soc. 2013, 20, 633.
88. [88]
  Petty, R.; Anthoney, A.; Metges, J. P.; Alsina, M.; Gonçalves, A.; Brown, J.; Montagut, C.; Gunzer, K.; Laus, G.; Iglesias Dios, J. L. Cancer Chemother. Pharmacol. 2016, 77, 819. doi: 10.1007/s00280-016-2991-0
1. [1]
  Haitang WANG , Yanni LING , Xiaqing MA , Yuxin CHEN , Rui ZHANG , Keyi WANG , Ying ZHANG , Wenmin WANG . Construction, crystal structures, and biological activities of two Ln^Ⅲ₃ complexes. Chinese Journal of Inorganic Chemistry, 2024, 40(8): 1474-1482. doi: 10.11862/CJIC.20240188
2. [2]
  Xin MA , Ya SUN , Na SUN , Qian KANG , Jiajia ZHANG , Ruitao ZHU , Xiaoli GAO . A Tb₂ complex based on polydentate Schiff base: Crystal structure, fluorescence properties, and biological activity. Chinese Journal of Inorganic Chemistry, 2024, 40(7): 1347-1356. doi: 10.11862/CJIC.20230357
3. [3]
  Siran Wang , Yinuo Wang , Yilong Zhao , Dazhen Xu . Advances in the Application and Preparation of Rhodanine and Its Derivatives. University Chemistry, 2025, 40(5): 318-327. doi: 10.12461/PKU.DXHX202407033
4. [4]
  Zhibei Qu , Changxin Wang , Lei Li , Jiaze Li , Jun Zhang . Organoid-on-a-Chip for Drug Screening and the Inherent Biochemistry Principles. University Chemistry, 2024, 39(7): 278-286. doi: 10.3866/PKU.DXHX202311039
5. [5]
  Quanliang Chen , Zhaohui Zhou . Research on the Active Site of Nitrogenase over Fifty Years. University Chemistry, 2024, 39(7): 287-293. doi: 10.3866/PKU.DXHX202310133
6. [6]
  Maitri Bhattacharjee , Rekha Boruah Smriti , R. N. Dutta Purkayastha , Waldemar Maniukiewicz , Shubhamoy Chowdhury , Debasish Maiti , Tamanna Akhtar . Synthesis, structural characterization, bio-activity, and density functional theory calculation on Cu(Ⅱ) complexes with hydrazone-based Schiff base ligands. Chinese Journal of Inorganic Chemistry, 2024, 40(7): 1409-1422. doi: 10.11862/CJIC.20240007
7. [7]
  Peng Zhan . Practice and Reflection in Training Medicinal Chemistry Graduate Students. University Chemistry, 2024, 39(6): 112-121. doi: 10.3866/PKU.DXHX202402022
8. [8]
  Jiahao Zeng , Hui Chao . 诱导程序性细胞死亡的金属抗肿瘤药物研究. University Chemistry, 2025, 40(6): 145-159. doi: 10.12461/PKU.DXHX202406019
9. [9]
  Yihui Song , Shangshang Qin , Kai Wu , Chengyun Jin , Bin Yu . 生物化学在高水平创新型药学人才培养中的交叉融合应用——以去甲基化酶LSD1抑制剂的活性评价为例. University Chemistry, 2025, 40(6): 341-352. doi: 10.12461/PKU.DXHX202406018
10. [10]
  Xiuya Ma , Yu Chen , Yan Zhang . Stories about Pharmaceuticals. University Chemistry, 2025, 40(7): 232-240. doi: 10.12461/PKU.DXHX202408003
11. [11]
  Ping Song , Nan Zhang , Jie Wang , Rui Yan , Zhiqiang Wang , Yingxue Jin . Experimental Teaching Design on Synthesis and Antitumor Activity Study of Cu-Pyropheophorbide-a Methyl Ester. University Chemistry, 2024, 39(6): 278-286. doi: 10.3866/PKU.DXHX202310087
12. [12]
  Ziheng Zhuang , Xiao Xu , Kin Shing Chan . Superdrugs for Superbugs. University Chemistry, 2024, 39(9): 128-133. doi: 10.3866/PKU.DXHX202309040
13. [13]
  Hao XU , Ruopeng LI , Peixia YANG , Anmin LIU , Jie BAI . Regulation mechanism of halogen axial coordination atoms on the oxygen reduction activity of Fe-N₄ site: A density functional theory study. Chinese Journal of Inorganic Chemistry, 2025, 41(4): 695-701. doi: 10.11862/CJIC.20240302
14. [14]
  Peihong Fan , Hongxiang Lou . 研究生高等天然药物化学课程的教学改革探索——导学互促式混合课堂教学与自主学习能力培养. University Chemistry, 2025, 40(6): 16-21. doi: 10.12461/PKU.DXHX202407078
15. [15]
  Rong Tian , Yadi Yang , Naihao Lu . Comprehensive Experimental Design of Undergraduate Students Based on Interdisciplinarity: Study on the Effect of Quercetin on Chlorination Activity of Myeloperoxidase. University Chemistry, 2024, 39(8): 247-254. doi: 10.3866/PKU.DXHX202312064
16. [16]
  Yukai Jiang , Yihan Wang , Yunkai Zhang , Yunping Wei , Ying Ma , Na Du . Characterization and Phase Diagram of Surfactant Lyotropic Liquid Crystal. University Chemistry, 2024, 39(4): 114-118. doi: 10.3866/PKU.DXHX202309033
17. [17]
  Jiayu Gu , Siqi Wang , Jun Ling . Kinetics of Living Copolymerization: A Brief Discussion. University Chemistry, 2025, 40(4): 100-107. doi: 10.12461/PKU.DXHX202406012
18. [18]
  Jingjing QING , Fan HE , Zhihui LIU , Shuaipeng HOU , Ya LIU , Yifan JIANG , Mengting TAN , Lifang HE , Fuxing ZHANG , Xiaoming ZHU . Synthesis, structure, and anticancer activity of two complexes of dimethylglyoxime organotin. Chinese Journal of Inorganic Chemistry, 2024, 40(7): 1301-1308. doi: 10.11862/CJIC.20240003
19. [19]
  Chunmei GUO , Weihan YIN , Jingyi SHI , Jianhang ZHAO , Ying CHEN , Quli FAN . Facile construction and peroxidase-like activity of single-atom platinum nanozyme. Chinese Journal of Inorganic Chemistry, 2024, 40(9): 1633-1639. doi: 10.11862/CJIC.20240162
20. [20]
  Congying Lu , Fei Zhong , Zhenyu Yuan , Shuaibing Li , Jiayao Li , Jiewen Liu , Xianyang Hu , Liqun Sun , Rui Li , Meijuan Hu . Experimental Improvement of Surfactant Interface Chemistry: An Integrated Design for the Fusion of Experiment and Simulation. University Chemistry, 2024, 39(3): 283-293. doi: 10.3866/PKU.DXHX202308097

Get Citation

PDF

XML

Metrics

PDF Downloads(104)
Abstract views(8786)
HTML views(3107)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142